Detailed answers about SERVIPHARM LIMITED, including incorporation, status, business activity, and accounts information.
When was SERVIPHARM LIMITED founded?
SERVIPHARM LIMITED was officially incorporated on 22 May 1989 and is registered under company number 02387405. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SERVIPHARM LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SERVIPHARM LIMITED?
SERVIPHARM LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SERVIPHARM LIMITED do?
SERVIPHARM LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 82990 - Other business support service activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is SERVIPHARM LIMITED's registered address?
The registered office address of SERVIPHARM LIMITED is 5 SANDRIDGE CLOSE, HARROW, MIDDLESEX, ENGLAND, HA1 1XD. This is the official address filed with Companies House for legal and statutory correspondence.
Is SERVIPHARM LIMITED financially stable?
The most recent accounts for SERVIPHARM LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.
Does SERVIPHARM LIMITED have any charges or mortgages?
SERVIPHARM LIMITED has 1 registered charge, of which 0 are outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.